HESTER BIOSCIENCES LTD
HESTERBIO · General/Diversified · NSE
₹1,942
Current Market Price
Fair Value (DCF)
₹1,249
Discount to FV
-35.7%
Updated just now
YieldIQ Score
50/100
Piotroski F-Score
7/9
Economic Moat
Moderate
Confidence
57%
ROE
15.4%
Debt/Equity
0.54
WACC
11.1%
Market Cap
₹1,652 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
19.0%
Return on capital employed
EV / EBITDA
12.0×
Enterprise multiple
Debt / EBITDA
2.2×
Leverage vs earnings
Interest Coverage
5.7×
EBIT covers interest
Current Ratio
1.56×
Short-term liquidity
Asset Turnover
0.51×
Revenue per ₹ of assets
Revenue CAGR (3Y)
7.7%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹1,942.4
Bear case
Discount -206.2%
Base case
Discount -55.5%
Bull case
Discount -31.7%
Ratio Trends
HESTERBIO · last 9 annual periods
ROE
15.4%
ROCE
19.0%
Operating Margin
—
Debt / Equity
0.54×
PE
19.3×
EV / EBITDA
12.0×
Historical Financials
HESTERBIO · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹235 Cr | ₹266 Cr | ₹305 Cr | ₹311 Cr | ₹333 Cr | +9.1% |
| EBITDA | ₹72.7 Cr | ₹66.0 Cr | ₹58.2 Cr | ₹69.1 Cr | ₹106 Cr | +9.8% |
| EBIT | ₹57.1 Cr | ₹45.1 Cr | ₹47.1 Cr | — | — | -4.7% |
| PAT | ₹39.3 Cr | ₹26.6 Cr | ₹18.9 Cr | ₹27.5 Cr | ₹55.6 Cr | +9.1% |
| EPS (diluted) | ₹46.41 | ₹0.00 | ₹24.88 | — | — | -14.4% |
| CFO | ₹8.7 Cr | ₹23.6 Cr | ₹48.2 Cr | ₹64.5 Cr | ₹64.1 Cr | +64.7% |
| CapEx | ₹-95.7 Cr | ₹-77.8 Cr | ₹-24.4 Cr | ₹-20.6 Cr | ₹-17.8 Cr | — |
| FCF | ₹-87.0 Cr | ₹-54.2 Cr | ₹23.8 Cr | ₹43.9 Cr | ₹46.3 Cr | — |
| Total Assets | ₹562 Cr | ₹670 Cr | ₹662 Cr | ₹653 Cr | ₹678 Cr | +4.8% |
| Total Debt | ₹228 Cr | ₹274 Cr | ₹244 Cr | ₹213 Cr | ₹195 Cr | -3.9% |
| Shareholders' Equity | ₹260 Cr | ₹280 Cr | ₹292 Cr | ₹314 Cr | ₹360 Cr | +8.5% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
Peers not yet ranked for HESTERBIO. Comparable companies and side-by-side valuation will appear here once the peer set is established.
Dividend History
14 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹41.00/sh
Last payout
2025-08-06
₹7.00
Peak payout
₹10.00
Trailing yield
0.36%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. HESTER BIOSCIENCES LTD (HESTERBIO.NS) trades at 1942.40 vs a model fair value of 1248.80, a gap of -35.7%. Piotroski F-score: 7/9. Moat l...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of HESTERBIO →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for HESTERBIO →
Compare
Head-to-head with peers
Compare HESTERBIO side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse HESTERBIONow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.